NTCOC
EW icon

Northern Trust Company of Connecticut’s Edwards Lifesciences EW Stock Holding History

Northern Trust Company of Connecticut’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$3.51M Sell
320,280
-494,034
-61% -$5.57M 0.02% 836
2013
Q3 		$9.45M Sell
814,314
-22,290
-3% -$261K 0.06% 455
2013
Q2 		$9.37M Buy
+836,604
New +$9.9M 0.06% 449

Other funds holding EW

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP
Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Northern Trust Company of Connecticut's EW Position: Q4 2013 in Review

Northern Trust Company of Connecticut reduced its Edwards Lifesciences (EW) stake by 61% in Q4 2013, selling an estimated $5.57M and leaving 320,280 shares worth $3.51M. The position accounts for 0.02% of the portfolio, ranked #836.

Northern Trust Company of Connecticut first reported a position in EW in Q2 2013 and has held it in 3 quarters since. The position peaked at $9.45M in Q3 2013. 408 funds tracked by Wall St. Rank hold EW as of Q4 2013.

  • Northern Trust Company of Connecticut held 320,280 shares of Edwards Lifesciences worth $3.51M as of Q4 2013.
  • Northern Trust Company of Connecticut sold 494,034 Edwards Lifesciences shares in Q4 2013, an estimated $5.57M.
  • Edwards Lifesciences made up 0.02% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #836 holding.
  • Northern Trust Company of Connecticut first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 3 quarters since.
  • Northern Trust Company of Connecticut's Edwards Lifesciences position peaked at $9.45M in Q3 2013.
  • 408 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.